This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (635)
-
February 03, 2026 | Insight SEP policies in EU, UK, draw US stakeholder scrutiny in Special 301 comments
...ACT argued that both countries should be placed on the Special 301 priority watch....
Sections: Antitrust, Intellectual Property, and Trade
-
January 23, 2026 | Official Statement Ramsay Health Care-National Capital Private Hospital deal to face Australian review
...New South Wales (NSW) and Nowra Private Hospital in Nowra, NSW.NCPH is a private hospital in Garran, ACT...
Sections: DealRisk® and Mergers and Acquisitions
-
January 16, 2026 | Comment Amid lagging SME participation in standards development, USPTO gets creative
...So far, so good, according to ACT Senior Global Policy Counsel Brian Scarpelli....
Sections: Antitrust and Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login